|Children ages 4-17 years with an osteoporotic fracture who are continuing treatment with GCs at a dose of≥0.1 mg/kg/day for &gt;3 months (high risk) We conditionally recommend treating with an oral or IV BP.|Very low|7.1b–7.2b|148–153|</p>